NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)
Grant Opportunity Analysis
The National Institute of Allergy and Infectious Diseases, part of NIH, is reissuing this funding opportunity for investigator-initiated Program Project (P01) grant applications supporting research aligned with the NIAID mission. The program seeks multi-project proposals with at least two related, synergistic Research Projects built around a common theme, plus an Administrative Core and optional Scientific Cores, covering topics such as infectious microbes, host-microbe interactions, immune function, and vaccines, therapeutics, and diagnostics for infectious and immune-mediated diseases. Clinical trials are not allowed, the maximum project period is five years, budgets are not limited, and applications must follow multi-project submission requirements; consultation with NIAID is strongly encouraged well before submission. Applications are due May 25, 2029, and submission requires SAM, UEI, eRA Commons, and Grants.gov registration, with questions directed to NIAID_P01_NOFO@mail.nih.gov.
Eligible Applicants
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.